University of Toronto, Ontario, Canada
Dr. Raymond Reilly is a professor and the Director of the Centre for Pharmaceutical Oncology at the Leslie Dan Faculty of Pharmacy, University of Toronto. His research is focused on the development, preclinical evaluation and advancement to first-in-humans clinical trials of novel radiopharmaceuticals for imaging and treatment of cancer. He has published more than 180 scientific papers in this field and has trained almost 40 graduate students in the radiopharmaceutical sciences. Professor Reilly’s research is supported by the Canadian Institutes of Health Research, the Canadian Cancer Society and the Natural Sciences and Engineering Research Council of Canada. He will be speaking on his recent work to develop radiation nanomedicines for local treatment of triple-negative breast cancer and glioblastoma multiforme, the most common and lethal form of brain cancer.